BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35308576)

  • 1. Effectiveness of 13-valent pneumococcal conjugate vaccine against hypoxic pneumonia and hospitalisation in Eastern Highlands Province, Papua New Guinea: An observational cohort study.
    Blyth CC; Britton KJ; Nguyen CD; Sapura J; Kave J; Nivio B; Chan J; Satzke C; Ford R; Kirarock W; Lehmann D; Pomat W; Russell FM
    Lancet Reg Health West Pac; 2022 May; 22():100432. PubMed ID: 35308576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of the 13-valent pneumococcal conjugate vaccine against hypoxic pneumonia in children in Lao People's Democratic Republic: An observational hospital-based test-negative study.
    Weaver R; Nguyen CD; Chan J; Vilivong K; Lai JYR; Lim R; Satzke C; Vongsakid M; Newton PN; Mulholland K; Gray A; Dubot-Pérès A; Dance DAB; Russell FM
    Lancet Reg Health West Pac; 2020 Sep; 2():100014. PubMed ID: 34327372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study.
    Homaira N; Strachan R; Quinn H; Beggs S; Bhuiyan M; Bowen A; Fawcett LK; Gilbert GL; Lambert SB; Macartney K; Marshall HS; Martin Md AC; McCallum G; McCullagh A; McDonald T; Selvadurai H; McIntyre P; Oftadeh S; Ranganathan PhD S; Saunders T; Suresh S; Wainwright C; Wilson A; Wong M; Jaffe A; Snelling T
    Vaccine; 2023 Jan; 41(1):85-91. PubMed ID: 36400662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictors of hypoxic pneumonia in children from the Eastern Highlands Province, Papua New Guinea: secondary analysis of two prospective observational studies.
    Britton KJ; Pomat W; Sapura J; Kave J; Nivio B; Ford R; Kirarock W; Moore HC; Kirkham LA; Richmond PC; Chan J; Lehmann D; Russell FM; Blyth CC
    Lancet Reg Health West Pac; 2024 Apr; 45():101052. PubMed ID: 38699291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
    Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
    BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia.
    Strachan R; Homaira N; Beggs S; Bhuiyan MU; Gilbert GL; Lambert SB; Macartney K; Marshall H; Martin AC; McCallum GB; McCullagh A; McDonald T; McIntyre P; Oftadeh S; Ranganathan S; Suresh S; Wainwright CE; Wilson A; Wong M; Snelling T; Jaffé A
    Thorax; 2021 May; 76(5):487-493. PubMed ID: 33504566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings.
    Ward KF; Trent M; Hull BP; Quinn HE; Dey A; Menzies RI
    BMC Health Serv Res; 2015 Mar; 15():109. PubMed ID: 25889782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study.
    Schuck-Paim C; Taylor RJ; Alonso WJ; Weinberger DM; Simonsen L
    Lancet Glob Health; 2019 Feb; 7(2):e249-e256. PubMed ID: 30683242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance.
    ; Mackenzie GA; Hill PC; Jeffries DJ; Ndiaye M; Sahito SM; Hossain I; Uchendu U; Ameh D; Adeyemi O; Pathirana J; Olatunji Y; Abatan B; Muhammad BS; Ahameefula E; Fombah AE; Adeshola B; Lobga BG; Saha D; Mackenzie R; Odutola A; Plumb ID; Akano A; Ebruke BE; Ideh RC; Kuti B; Githua P; Olutunde E; Ofordile O; Green E; Usuf E; Badji H; Ikumapayi UN; Manjang A; Salaudeen R; Nsekpong ED; Jarju S; Antonio M; Sambou S; Ceesay L; Lowe-Jallow Y; Fofana S; Jasseh M; Mulholland K; Knoll M; Levine OS; Howie SR; Adegbola RA; Greenwood BM; Corrah T
    Lancet Infect Dis; 2021 Sep; 21(9):1293-1302. PubMed ID: 34280357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood pneumonia and meningitis in the Eastern Highlands Province, Papua New Guinea in the era of conjugate vaccines: study methods and challenges.
    Blyth CC; Ford R; Sapura J; Kumani T; Masiria G; Kave J; Yuasi L; Greenhill A; Hwaihwanje I; Lang A; Lehmann D; Pomat W;
    Pneumonia (Nathan); 2017; 9():5. PubMed ID: 28702307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study.
    Fathima P; Gidding HF; McIntyre PB; Snelling TL; McCallum L; de Klerk N; Blyth CC; Liu B; Moore HC
    Lancet Child Adolesc Health; 2019 Oct; 3(10):713-724. PubMed ID: 31439496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study.
    Chan J; Gidding HF; Blyth CC; Fathima P; Jayasinghe S; McIntyre PB; Moore HC; Mulholland K; Nguyen CD; Andrews R; Russell FM
    PLoS Med; 2021 Aug; 18(8):e1003733. PubMed ID: 34343186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.
    Lucero MG; Nohynek H; Williams G; Tallo V; Simões EA; Lupisan S; Sanvictores D; Forsyth S; Puumalainen T; Ugpo J; Lechago M; de Campo M; Abucejo-Ladesma E; Sombrero L; Nissinen A; Soininen A; Ruutu P; Riley I; Mäkelä HP
    Pediatr Infect Dis J; 2009 Jun; 28(6):455-62. PubMed ID: 19483514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting.
    Johnstone SL; Moore DP; Klugman KP; Madhi SA; Groome MJ
    Paediatr Int Child Health; 2020 Feb; 40(1):50-57. PubMed ID: 31156062
    [No Abstract]   [Full Text] [Related]  

  • 15. Pneumococcal conjugate vaccine--a health priority.
    Zar HJ; Madhi SA
    S Afr Med J; 2008 Jun; 98(6):463-7. PubMed ID: 18683380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016.
    Vila-Corcoles A; Hospital I; Ochoa-Gondar O; Satue E; de Diego C; Vila-Rovira A; Gómez-Bertomeu F; Raga X; Aragón M
    Vaccine; 2020 Jan; 38(5):1170-1180. PubMed ID: 31759735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study.
    Vila-Corcoles A; Ochoa-Gondar O; de Diego C; Satue E; Aragón M; Vila-Rovira A; Gomez-Bertomeu F; Magarolas R; Figuerola-Massana E; Raga X; Perez MO; Ballester F
    BMC Infect Dis; 2018 Apr; 18(1):196. PubMed ID: 29699550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China.
    Mo X; Gai Tobe R; Liu X; Mori R
    Pediatr Infect Dis J; 2016 Nov; 35(11):e353-e361. PubMed ID: 27753771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants.
    Pomat WS; van den Biggelaar AHJ; Wana S; Francis JP; Solomon V; Greenhill AR; Ford R; Orami T; Passey M; Jacoby P; Kirkham LA; Lehmann D; Richmond PC;
    Clin Infect Dis; 2019 Apr; 68(9):1472-1481. PubMed ID: 30184183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.